Skip to content
lifestyle.hubspotes.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Whitehawk Therapeutics, Inc.
Whitehawk Therapeutics Presents Real-World Analyses Supporting PTK7 as a Durable ADC Target in EGFR Wild-Type Non-Small Cell Lung Cancer at WCLC 2026
September 13, 2026
Whitehawk Therapeutics Appoints Vijay Iyengar, MD, to Board of Directors
September 10, 2026
Whitehawk Therapeutics to Participate in Upcoming Investor Conferences
September 2, 2026
Whitehawk Therapeutics Reports Second Quarter 2026 Financial Results and Recent Highlights
August 6, 2026